# Aquestive Therapeutics, Inc.: Form 8-K, filed Feb 26, 2026

- Company: [Aquestive Therapeutics, Inc.](/companies/aqst.md) (CIK 1398733)
- Form: 8-K
- Filed: 2026-02-26
- Accepted by EDGAR: Feb 26, 2026, 08:07 ET
- Period: 2026-02-26
- Accession: 0001398733-26-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000007/aqst-20260226.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000007/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1398733/000139873326000007/aqst-20260226.htm

Filed Feb 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001398733-26-000007. Last ingested by Listed: Nov 5, 2026, 18:09 ET. No prices; not investment advice.